Resumen de No vacillation on HPV vaccination

Douglas Sipp, Ian H. Frazer, John J. E. Rasko

• Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across countries and falls short of levels needed to achieve population immunity. We highlight policy measures that would help ensure greater worldwide coverage and save lives.